Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 26, 2002 - Issue 3
48
Views
18
CrossRef citations to date
0
Altmetric
Original

DECREASED MORBIDITY IN HOMOZYGOUS SICKLE CELL DISEASE DETECTED AT BIRTH

Pages 211-217 | Received 26 Mar 2002, Accepted 30 Apr 2002, Published online: 07 Jul 2009

REFERENCES

  • Gill F. M., Sleeper L. A., Weiner S. J., Brown A. K., Bellevue R., Grover R., Pegelow C. H., Vichinsky E. Clinical Events in the First Decade in a Cohort of Infants with Sickle Cell Disease. Blood 1995; 86(2)776–783
  • Lee A., Thomas P., Cupidore L., Serjeant B., Serjeant G. Improved Survival in Homozygous Sickle Cell Disease: Lessons from a Cohort Study. Br. Med. J. 1995; 311: 1600–1602
  • Thomas C., Lemerle S., Bernaudin F., Feingold J., Guillou-Bataille M., Reinert P. Drépanocytose: Étude de la Mortalité Pédiatrique en Ile-de-France de 1985 à 1992. Arch. Pédiatr. 1996; 3: 445–451
  • Gaston M. H., Verter J. I., Woods G., Pegelow C., Kelleher J., Presbury G., Zarkowsky H., Vichinsky E., Iyer R., Lobel J. S., Diamond S., Holbrook T., Gill F. M., Ritchey K., Falletta J. M. Prophylaxis with Oral Penicillin in Children with Sickle Cell Anemia. N. Engl. J. Med. 1986; 314(25)1594–1599
  • Vichinsky E., Hurst D., Earles A., Kleman K., Lubin B. Newborn Screening for Sickle Cell Disease: Effect on Mortality. Pediatrics 1988; 81(6)749–755
  • Shafer F. E., Lorey F., Cunningham G. C., Klumpp C., Vichinsky E., Lubin B. Newborn Screening for Sickle Cell Disease: 4 Years of Experience for California's Newborn Screening Program. J. Pediatr. Hematol./Oncol. 1996; 18(1)36–41
  • de Montalembert M., Guilloud-Bataille M., Feingold J., Girot R. Epidemiological and Clinical Study of Sickle Cell Disease in France, French Guiana and Algeria. Eur. J. Haematol. 1993; 51: 136–140
  • Bardakjian J., Ducrocq R., de Montalembert M., Benkerrou M., Bernaudin F., Brahimi L., Hurtrel D., Farriaux J. P., Elion J., Galactéros F. (1998) Newborn Screening for Sickle Cell Disease (SCD):. AmsterdamThe Netherlands, July, 4–81998. AmsterdamThe Netherlands, 3 Years of Experience from Parisian Area's Screening Program. International Society of Hematology-European Hematology Association, Combined Hematology Congress
  • Miller S. T., Sleeper L. A., Pegelow C. H., Enos L. E., Wang W. C., Weiner S. J., Wethers D. L., Smith J., Kinney T. R. Prediction of Adverse Outcomes in Children with Sickle Cell Disease. N. Engl. J. Med. 2000; 342(2)83–89
  • Emond A. M., Collis R., Darvill D., Higgs D. R., Maude G. H., Serjeant G. R. Acute Splenic Sequestration in Homozygous Sickle Cell Disease: Natural History and Management. J. Pediatr. 1985; 107: 201–206
  • Brock D.J. H. Cystic Fibrosis. Neonatal Screening, Annales Nestlé. 1998; 56: 109–116

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.